ZA892397B - The human c3b/c4b receptor(cr1) - Google Patents
The human c3b/c4b receptor(cr1)Info
- Publication number
- ZA892397B ZA892397B ZA892397A ZA892397A ZA892397B ZA 892397 B ZA892397 B ZA 892397B ZA 892397 A ZA892397 A ZA 892397A ZA 892397 A ZA892397 A ZA 892397A ZA 892397 B ZA892397 B ZA 892397B
- Authority
- ZA
- South Africa
- Prior art keywords
- fragments
- expression
- protein
- secreted
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Joining Of Building Structures In Genera (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17653288A | 1988-04-01 | 1988-04-01 | |
US41274589A | 1989-09-26 | 1989-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA892397B true ZA892397B (en) | 1989-11-29 |
Family
ID=26872337
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA892397A ZA892397B (en) | 1988-04-01 | 1989-03-31 | The human c3b/c4b receptor(cr1) |
ZA907693A ZA907693B (en) | 1988-04-01 | 1990-09-26 | The human c3b/c4b receptor(cr1) |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA907693A ZA907693B (en) | 1988-04-01 | 1990-09-26 | The human c3b/c4b receptor(cr1) |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0411031B1 (no) |
JP (1) | JP3484189B2 (no) |
CN (2) | CN1092712C (no) |
AT (1) | ATE240973T1 (no) |
CA (2) | CA1341443C (no) |
DE (1) | DE68929466T2 (no) |
DK (1) | DK175699B1 (no) |
ES (1) | ES2014593A6 (no) |
FI (2) | FI106316B (no) |
IL (1) | IL89790A (no) |
NO (1) | NO315944B1 (no) |
SG (1) | SG52789A1 (no) |
WO (1) | WO1989009220A1 (no) |
ZA (2) | ZA892397B (no) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5426029A (en) * | 1986-03-31 | 1995-06-20 | T Cell Diagnostics, Inc. | Therapeutic and diagnostic methods using leukocyte surface antigens |
US5256642A (en) * | 1988-04-01 | 1993-10-26 | The Johns Hopkins University | Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
US6482404B1 (en) | 1989-10-12 | 2002-11-19 | David James White | Transplantation of tissue comprising a DNA sequence encoding a homologous complement restriction factor |
ES2060561T3 (es) * | 1989-10-12 | 1996-08-01 | Imutran Ltd | Material biologico modificado. |
US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
US6458360B1 (en) * | 1990-04-25 | 2002-10-01 | The Johns Hopkins University | Soluble complement regulatory molecules |
ATE158816T1 (de) * | 1990-11-26 | 1997-10-15 | Genetics Inst | Expression von pace in wirtszellen und verfahren zu dessen verwendung |
WO1992010205A1 (en) * | 1990-12-06 | 1992-06-25 | T Cell Sciences, Inc. | Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
EP1413587A2 (en) * | 1991-05-03 | 2004-04-28 | Washington University | Modified complement system regulator |
EP0649468B1 (en) * | 1992-06-24 | 2000-03-15 | AdProTech plc | Soluble cr1 derivatives |
US5456909A (en) * | 1992-08-07 | 1995-10-10 | T Cell Sciences, Inc. | Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo |
JP3689422B2 (ja) * | 1993-02-12 | 2005-08-31 | アーヴァント イミュノセラピューティクス インコーポレイテッド | sCR1およびその他の補体阻害蛋白の肺内投与 |
EP0921816A4 (en) | 1996-03-28 | 2004-09-22 | Whitehead Biomedical Inst | CELLS WITH INCREASED OPSONINE CONTENT AND METHOD FOR REGULATING AN IMMUNE RESPONSE TO ANTIQUE |
TW555765B (en) | 1996-07-09 | 2003-10-01 | Amgen Inc | Low molecular weight soluble tumor necrosis factor type-I and type-II proteins |
GB9706950D0 (en) * | 1997-04-05 | 1997-05-21 | Chernajovsky Yuti | Immune modulation by polypeptides related to CR1 |
WO2000005413A1 (en) * | 1998-07-24 | 2000-02-03 | Uab Research Foundation | Genetic polymorphism in a complement receptor |
US6664052B1 (en) | 1998-07-24 | 2003-12-16 | The Uab Research Foundation | Genetic polymorphism in a complement receptor |
GB9905503D0 (en) | 1999-03-10 | 1999-05-05 | Adprotech Plc | Novel compound formulations and methods of delivery |
EP1738763A1 (en) | 2005-06-30 | 2007-01-03 | AVANT Immunotherapeutics, Inc. | Use of complement inhibitory proteins to treat spinal cord injury |
CA3154415A1 (en) | 2006-10-10 | 2008-04-17 | Regenesance B.V. | Anti-sense oligonucleotide for use in facilitating axonal regeneration |
EP2350274B1 (en) | 2008-10-21 | 2019-01-23 | The General Hospital Corporation | Cell transplantation |
WO2012019103A2 (en) | 2010-08-06 | 2012-02-09 | The General Hospital Corporation D/B/A | System and apparatus for cell treatment |
CN107661491A (zh) | 2010-09-15 | 2018-02-06 | 赛尔戴克斯治疗公司 | 用可溶性I型补体受体(sCR1)治疗慢性肾病 |
US9649356B2 (en) | 2010-10-27 | 2017-05-16 | Celldex Therapeutics, Inc. | Method of improving transplant function using soluble complement receptor type I (sCR1) |
JP5859557B2 (ja) * | 2010-11-02 | 2016-02-10 | カイファ, インコーポレイテッド | 補体活性化についての側方流動イムノアッセイおよび補体関連障害のポイント・オブ・ケア評価のための使用法 |
CN102702339B (zh) * | 2011-05-24 | 2013-10-30 | 华南师范大学 | 斜带石斑鱼补体c3基因、载体、重组菌株和蛋白及其应用 |
CA2857168C (en) * | 2011-12-01 | 2020-10-27 | Protevobio, Inc. | Protein inhibitors to complement and vegf pathways and methods of use thereof |
US10531655B2 (en) | 2011-12-02 | 2020-01-14 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
CN104293836A (zh) * | 2014-06-24 | 2015-01-21 | 长沙赢润生物技术有限公司 | 一种免疫复合物吸附细胞的制作方法 |
GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
EP3760645A1 (en) * | 2019-07-02 | 2021-01-06 | imusyn GmbH & Co. KG | Analysis for blood group antigen dacy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60192948A (ja) * | 1984-03-14 | 1985-10-01 | Fuji Photo Film Co Ltd | 湿し水不要ネガ型感光性平版印刷版および製版方法 |
US4672044A (en) * | 1984-08-24 | 1987-06-09 | Scripps Clinic & Research Foundation | Murine monoclonal antibody combining site to human C3b receptor (CR1) |
-
1989
- 1989-03-29 IL IL8979089A patent/IL89790A/en active IP Right Grant
- 1989-03-31 SG SG1996009545A patent/SG52789A1/en unknown
- 1989-03-31 DE DE68929466T patent/DE68929466T2/de not_active Expired - Fee Related
- 1989-03-31 AT AT89905249T patent/ATE240973T1/de not_active IP Right Cessation
- 1989-03-31 WO PCT/US1989/001358 patent/WO1989009220A1/en active IP Right Grant
- 1989-03-31 CA CA000617127A patent/CA1341443C/en not_active Expired - Fee Related
- 1989-03-31 EP EP89905249A patent/EP0411031B1/en not_active Expired - Lifetime
- 1989-03-31 JP JP50500089A patent/JP3484189B2/ja not_active Expired - Fee Related
- 1989-03-31 CA CA000595389A patent/CA1340866C/en not_active Expired - Fee Related
- 1989-03-31 ES ES8901125A patent/ES2014593A6/es not_active Expired - Lifetime
- 1989-03-31 ZA ZA892397A patent/ZA892397B/xx unknown
- 1989-04-01 CN CN89101990A patent/CN1092712C/zh not_active Expired - Fee Related
-
1990
- 1990-09-26 CN CN90108145A patent/CN1053924C/zh not_active Expired - Fee Related
- 1990-09-26 ZA ZA907693A patent/ZA907693B/xx unknown
- 1990-09-28 DK DK199002348A patent/DK175699B1/da not_active IP Right Cessation
- 1990-10-01 FI FI904842A patent/FI106316B/fi active IP Right Grant
-
2000
- 2000-02-18 NO NO20000827A patent/NO315944B1/no not_active IP Right Cessation
- 2000-11-16 FI FI20002515A patent/FI115528B/fi active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN1053924C (zh) | 2000-06-28 |
CA1341443C (en) | 2003-10-07 |
CA1340866C (en) | 1999-12-28 |
DK234890D0 (da) | 1990-09-28 |
NO20000827L (no) | 1990-11-09 |
NO20000827D0 (no) | 2000-02-18 |
DK234890A (da) | 1990-11-30 |
DE68929466T2 (de) | 2004-04-01 |
AU647371B2 (en) | 1994-03-24 |
FI904842A0 (fi) | 1990-10-01 |
CN1053265A (zh) | 1991-07-24 |
JP3484189B2 (ja) | 2004-01-06 |
FI115528B (fi) | 2005-05-31 |
EP0411031A1 (en) | 1991-02-06 |
FI106316B (fi) | 2001-01-15 |
IL89790A0 (en) | 1989-09-28 |
FI20002515A (fi) | 2000-11-16 |
CN1092712C (zh) | 2002-10-16 |
JPH04501502A (ja) | 1992-03-19 |
ATE240973T1 (de) | 2003-06-15 |
ZA907693B (en) | 1992-05-27 |
AU3539489A (en) | 1989-10-16 |
SG52789A1 (en) | 1998-09-28 |
IL89790A (en) | 2002-05-23 |
DK175699B1 (da) | 2005-01-24 |
DE68929466D1 (de) | 2003-06-26 |
EP0411031A4 (en) | 1992-02-05 |
EP0411031B1 (en) | 2003-05-21 |
CN1036987A (zh) | 1989-11-08 |
WO1989009220A1 (en) | 1989-10-05 |
ES2014593A6 (es) | 1990-07-16 |
NO315944B1 (no) | 2003-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0502892A4 (en) | The human c3b/c4b receptor (cr1) | |
SG52789A1 (en) | The human C3B/C4B receptor (cr1) | |
Seidman et al. | The structure of rat preproatrial natriuretic factor as defined by a complementary DNA clone | |
US5401651A (en) | DNA encoding ENA-78, a neutrophil activating factor | |
KR970705405A (ko) | 사람 케모킨 폴리펩타이드(Human Chemokine Polypeptides) | |
CA2529179A1 (en) | Recombinant adeno-associated virus vector for treatment of alzheimer disease | |
HUT77578A (hu) | A 10-es számú fibroblaszt növekedési faktor (FGF-10) | |
Dewji et al. | Nucleotide sequence of cloned cDNA for human sphingolipid activator protein 1 precursor. | |
NZ503235A (en) | Amino-terminally truncated RANTES as chemokine antagonists | |
CA2062969A1 (en) | Recombinantly produced human membrane cofactor protein (mcp) | |
MX9203654A (es) | Purificacion, clonacion y caracterizacion del gen para la interleucina i. | |
PT98695A (pt) | Gene codificador do factor neurotrofico de ligacao a heparina | |
EP0913470A3 (en) | The human C3b/C4b receptor (CR1) | |
KR930701475A (ko) | 사람의 거핵구-집락 촉진 인자(hMeg-CSF) 및 그것의 생산방법 | |
BR0208140A (pt) | Polipeptìdeo, agente imunoterapêutico para o tratamento de psorìase, sequência de ácido nucléico isolada ou seu complemento, vetores de filamento único, e de filamento duplo, sequência de ácido nucléico isolada ou variante imunogênica da mesma, métodos para a produção de polipeptìdeos, e para o tratamento e a remissão clìnica de psorìase, e, célula hospedeira microbiana | |
EP0308424A1 (en) | A novel protein, neuroleukin | |
EP0341100A2 (en) | DNA coding for thymosin and TNF | |
WO1998004692A3 (en) | Human neuronatin | |
JPH07309778A (ja) | 創傷治療剤 |